114 related articles for article (PubMed ID: 12586812)
21. Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.
Sorbye SW; Kilvaer TK; Valkov A; Donnem T; Smeland E; Al-Shibli K; Bremnes RM; Busund LT
PLoS One; 2012; 7(10):e47068. PubMed ID: 23071715
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
[TBL] [Abstract][Full Text] [Related]
23. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of Skp2 and p27 in human breast cancer.
Traub F; Mengel M; Lück HJ; Kreipe HH; von Wasielewski R
Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894
[TBL] [Abstract][Full Text] [Related]
25. [Multivariate survival analysis in patient with laryngeal squamous cell carcinomas].
Guo J; Chen F; Guan Z; Chen Y; Li Q; Ouyang D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jul; 20(14):636-9. PubMed ID: 17017186
[TBL] [Abstract][Full Text] [Related]
26. The F box protein S phase kinase-associated protein 2 regulates adipose mass and adipocyte number in vivo.
Cooke PS; Holsberger DR; Cimafranca MA; Meling DD; Beals CM; Nakayama K; Nakayama KI; Kiyokawa H
Obesity (Silver Spring); 2007 Jun; 15(6):1400-8. PubMed ID: 17557977
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.
Hershko DD
Cancer; 2008 Apr; 112(7):1415-24. PubMed ID: 18260093
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study.
Liu Z; Fu Q; Lv J; Wang F; Ding K
J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157
[TBL] [Abstract][Full Text] [Related]
29. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
Ben-Izhak O; Lahav-Baratz S; Meretyk S; Ben-Eliezer S; Sabo E; Dirnfeld M; Cohen S; Ciechanover A
J Urol; 2003 Jul; 170(1):241-5. PubMed ID: 12796697
[TBL] [Abstract][Full Text] [Related]
30. Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma.
Fukuchi M; Masuda N; Nakajima M; Fukai Y; Miyazaki T; Kato H; Kuwano H
Anticancer Res; 2004; 24(2B):777-83. PubMed ID: 15161026
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G
Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054
[TBL] [Abstract][Full Text] [Related]
32. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
[TBL] [Abstract][Full Text] [Related]
33. Nuclear expression of S-phase kinase-associated protein 2 predicts poor prognosis of hepatocellular carcinoma.
Shin E; Kim SH; Jeong HY; Jang JJ; Lee K
APMIS; 2012 May; 120(5):349-57. PubMed ID: 22515289
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
Goto A; Niki T; Moriyama S; Funata N; Moriyama H; Nishimura Y; Tsuchida R; Kato JY; Fukayama M
Pathol Int; 2004 Sep; 54(9):675-81. PubMed ID: 15363035
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of Skp2 expression in Egyptian diffuse large B-cell lymphoma.
Abdou AG; Asaad NY; Abd El-Wahed MM; Samaka RM; Allah MS
Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):47-55. PubMed ID: 21558842
[TBL] [Abstract][Full Text] [Related]
36. Significance of skp2 expression in primary breast cancer.
Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
[TBL] [Abstract][Full Text] [Related]
37. Associations and prognostic significance of p27
Ma Y; Yan M; Huang H; Zhang L; Wang Q; Zhao Y; Zhao J
Mol Clin Oncol; 2016 Oct; 5(4):357-364. PubMed ID: 27703676
[TBL] [Abstract][Full Text] [Related]
38. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Voduc D; Nielsen TO; Cheang MC; Foulkes WD
Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
[TBL] [Abstract][Full Text] [Related]
39. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
40. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma.
Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD
Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]